In patients with cystic fibrosis, CMTX-101, an immune-enabling antibody therapy, lowered four inflammatory biomarkers and ...

Cystic fibrosis causes a buildup of mucus in the lungs that can lead to infection, and often death in children and young ...

The cost of medication was too high for thousands of CF sufferers around the world. Now a Bangladeshi company is making a generic version that will change lives ...

The stock's 14-day relative strength index (RSI) is 82.46. For the uninitiated, a level above 70 is considered overbought or ...

The CF API combination involves advanced chemistry, multi-step synthesis, and specialised reactions, resulting in high ...

Sigachi Industries introduces a new Cystic Fibrosis API combination, enhancing its strategic focus on complex specialty ...

Cystic fibrosis is a chronic genetic condition that causes thick, sticky mucus to build up in your lungs. This often leads to frequent respiratory infections and gastrointestinal (GI) problems. If you ...

Lee University will host the annual Great Strides Walk and 65 Roses 5k at Great Strides on Saturday, March 28. An event of ...

According to the filing, based on the company's internal assessment, Sigachi is exploring strategic partnerships with ...

Imagine being told as a child that you were so sick that you’d never live into adulthood. Then suddenly you’re in your 30s ...

Sigachi Industries announced a significant milestone in its research and development pipeline with the successful advancement of a new Cystic Fibrosis (CF) Active Pharmaceutical Ingredients (APIs) ...